Louis Lehot on Biotech IPOs – 'Biotech could have a great fourth quarter'
04 September 2024
Bloomberg Law
Foley & Lardner LLP partner Louis Lehot offered insight on the biotech industry’s upcoming initial public offerings in the Bloomberg Law article, “Biotech IPO Hopefuls Ready Burst of Debuts After Rough Stretch.”
“Biotech could have a great fourth quarter, we have a great pipeline,” Lehot commented, as several biotech companies look to reignite the sector with upcoming IPOs. “Biotech IPOs are here and ready to put money to work.”
(Subscription required)
People
Related News
22 November 2024
In the News
Foley Attorneys Explore Upjohn Warnings in Health Care Compliance Investigations
Foley & Lardner LLP attorneys Mark Neuberger, Kate Pamperin, and Lawrence Vernaglia authored the article, "Whose Lawyer Is it Anyway: Understanding the Upjohn Warning in Health Care Compliance Investigations,"
22 November 2024
In the News
Foley Partners with Utah Business to Host Quantum and Cloud Computing Roundtable
Foley & Lardner LLP recently partnered with Utah Business to host a roundtable discussion featuring leaders in quantum and cloud computing from across the state.
21 November 2024
In the News
Nathaniel Lacktman Weighs in on DEA Telemedicine Prescribing Extension
Foley & Lardner LLP partner Nathaniel Lacktman shared insight on the U.S. Drug Enforcement Agency’s recent one-year extension of flexibilities for telemedicine prescribing in the STAT Health Tech newsletter.